Executive Search: Look No Further

Research, Relationships, Results

Expertise

To Us, It’s Personal

Every search we undertake means more to us than a signed contract and a filled position. We make it our business to understand a client’s needs for the present and the future. That takes innovation, diligence and communication, paired with robust research capabilities and a vast network of long-term relationships. We value people over transactions and know relationships equal results.

About Us

Industries

Raising the Standard, Going Beyond

We identify game-changing leaders for every position, across all industries. The best talent isn’t always immediately obvious, and that’s just fine with us. Digging deeper and thinking creatively are embedded in our DNA.

Learn More

History

40 Years of Excellence

We’ve learned a lot throughout the past 40 years. Industries change, technology evolves, roles expand, but one truth remains the same–people matter. Long-standing client relationships are the foundation of The Alexander Group and that will never change.

Learn More

Team

We’re in the Relationship Business

We say it all the time—relationships matter. That starts within The Alexander Group culture and extends to our clients. The foundation of any strong relationship is respect, communication, and transparency, and we prioritize all three with every single client. All organizations seek transformational leaders that bring out the best in their team and have lasting impact. We are an executive search firm connecting the dots.

Meet the Team

Blog

Know What We Know

Explore recent searches, plus our insights and musings on industry trends, current events and topics of interest in our blog section.

Ole Wendler Pedersen has been named EVP Legal & General Counsel at STADA Arzneimittel AG. Mr. Wendler Pedersen is a strategic, globally experienced General Counsel with over 20 years of leadership experience spanning private practice and European-based, publicly listed pharmaceutical companies. Mr. Wendler Pedersen has a proven track record in advising Boards and Executive Management,

Christina Rossi has been appointed to CG Oncology’s Board of Directors. Ms. Rossi is an experienced biopharmaceutical executive leader and board member with an established track record of building and leading exceptional organizations to create value. Ms. Rossi most recently served as Chief Operating Officer of Blueprint Medicines from 2022 until its acquisition by Sanofi

It’s funny what can happen in a year. If you’d asked The Alexander Group team about AI usage at the end of 2024, most of us would have admitted familiarity with ChatGPT and the general concept of AI. Still, many of us had yet to dive in, much less dip a toe into the swiftly